Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
69,051
datasets available to search
ShareScore release 0.7.1
Dataset results
69,051 results for “Cancer”
GERONTE H2020 project - GERDAT006 - Dataset of symptoms and proms for specific cancer types and gender
<p>This dataset describes a series of symptoms, potentially indicative of treatment-related complications, destabilised comorbidity or functional decline, to be used in the Geronte project for symptoms monitoring in older patients with multimorbidity during and after their cancer treatment</p>
Improving The Diagnosis of Thyroid Cancer by Machine Learning and Clinical Data
<p>This repository contains the dataset used in the paper "Improving The Diagnosis of Thyroid Cancer by Machine Learning and Clinical Data" published in <strong>Scientific Reports</strong>. Please check our <a href="https://www.nature.com/articles/s41598-022-15342-z">formal publication</a> for the full details. The dataset contains 1232 nodules from 724 patients. Each row represents one nodule and each column represents one variable that describes the characteristics of the patient or nodule. The meaning of each variable is summarized below.</p> <ul> <li>id: the unique identity of the patient who carries the nodule</li> <li>age: the age of the patient</li> <li>FT3: triiodothyronine test result</li> <li>FT4: thyroxine test result</li> <li>TSH: thyroid-stimulating hormone test result</li> <li>TPO: thyroid peroxidase antibody test result</li> <li>TGAb: thyroglobulin antibodies test result</li> <li>site: the nodule location, 0: right, 1: left, 2: isthmus</li> <li>echo_pattern: thyroid echogenicity, 0: even, 1: uneven</li> <li>multifocality: if multiple nodules exist in one location, 0: no, 1: yes</li> <li>size: the nodule size in cm</li> <li>shape: the nodule shape, 0: regular, 1: irregular</li> <li>margin: the clarity of nodule margin, 0: clear; 1: unclear</li> <li>calcification: the nodule calcification, 0: absent, 1: present</li> <li>echo_strength: the nodule echogenicity, 0: none, 1: isoechoic, 2: medium-echogenic, 3: hyperechogenic, 4: hypoechogenic</li> <li>blood_flow: the nodule blood flow, 0: normal, 1: enriched</li> <li>composition: the nodule composition, 0: cystic, 1: mixed, 2: solid</li> <li>multilateral: if nodules occur in more than one location, 0: no, 1: yes</li> <li>mal: the nodule malignancy, 0: benign, 1: malignant</li> </ul>
Supplementary material for "Towards a metagenomics machine learning interpretable model for understanding the transition from adenoma to colorectal cancer"
<p>Supplementary files for "Towards a metagenomics machine learning interpretable model for understanding the transition from adenoma to colorectal cancer".</p>
NanoString dataset for study: Impairment of cancer-associated fibroblasts promotes CD8+ T cell infiltration and enhances sensitivity to immune checkpoint blockade
<p>Pre-processed NanoString mRNA abundance data and associated sample sheet for study:</p> <p>Impairment of cancer-associated fibroblasts promotes CD8+ T cell infiltration and enhances sensitivity to immune checkpoint blockade</p>
Multi-omic machine learning predictor of breast cancer therapy response
<p>H&E slides used in the training dataset described in "Multi-omic machine learning predictor of breast cancer therapy response" published in <em>Nature</em>: <a href="https://www.nature.com/articles/s41586-021-04278-5">https://www.nature.com/articles/s41586-021-04278-5</a></p> <p>Metadata associated with these images also included in file Slide metadata.xlsx</p>
Data of FigS7, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of FigS7, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_FigS7.PNG). The Corresponding raw data and subsequent data analysis obtained contains one file in txt-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_23_1_M .txt) and one file as csv-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_12_1.csv).</p>
GERDAT011 Literature search for publication - Geriatric assessment in the management of older patients with cancer – a systematic review (update).xlsx
<p>Search data belonging to the publication Geriatric assessment in the management of older patients with cancer – a systematic review (update)</p>
GERDAT010 Dataset for literature search linked to publication "Information needs of older patients newly diagnosed with cancer"
<p>Dataset of the literature search belonging to the publication "Information needs of older patients newly diagnosed with cancer"</p>
Regional Models of Canine Cancer Incidences
<p>The dataset consists of the variables implemented in the regional models of canine cancer incidences (dogCancerModel.txt), the adjacency matrix determining the regions (kNearestNeighbour.txt), and the Swiss municipal boundaries (SwissMunicipalities_2015.shp).</p>
Joint AstraZeneca-Cancer Research Horizons Functional Genomics Centre's CRISPRn library benchmark screens: gRNA counts and associated metadata
<p>Genome-wide CRISPR sgRNA libraries have emerged as transformative tools to systematically probe gene function. While these libraries have been iterated over time to be more efficient, their large size limits their use in some applications. Here, we benchmarked publicly available genome-wide single-targeting sgRNA libraries and evaluated dual targeting as a strategy for pooled CRISPR loss-of-function screens. We leveraged this data to design two minimal genome-wide human CRISPR-Cas9 libraries that are 50% smaller than other libraries and that preserve specificity and sensitivity, thus enabling broader deployment at scale. </p>
Evaluation of transcription factor knockout impact on paclitaxel response for Triple Negative Breast Cancer
<div>Data and code related to Zenodo repository: 10.5281/zenodo.11238552</div> <div> </div> <div>Two experimental formats included:</div> <div>'fixed' prefix: data from terminal time point of siRNA screen applied to HCC1143, HCC1806, and MDA-MB-468 Triple Negative Breast Cancer cell lines.</div> <div>'live' prefix: data from live-cell imaging of cell cycle reporter (HDHB-mClover/NLS-mCherry) HCC1143 Triple Negative Breast Cancer cell line.</div> <div>Note: 'live' level 1 data is available upon request (heiserl@ohsu.edu, calistri@ohsu.edu).</div> <div> </div> <div>Experimental goal:</div> <div>Evaluate whether siRNA knockdown of transcription factors elevated during paclitaxel response impact cell count, cell morphology or cycling dynamics.</div> <div> </div> <div>Methods:</div> <div>siRNA Knockdown: Cells were plated in 90ul of serum free media per well of a 96 well plate. 24 hours later, siRNA knockdown mixture was prepared using a cell-line optimized concentration of Lipofectamine RNAiMAX (cat 13778075-075, Invitrogen) and siRNA (Horizon Discovery ON-TARGETplus) following RNAiMAX recommended protocol. The final concentration of siRNA per well was 1pmol and the final volume of RNAiMAX per well was 75nL for HCC1143, and 37.5nL for HCC1806 or MDA-MB-468 in 100uL of cell containing volume. 24 hours after siRNA transfection cells were treated with an addition of 100uL complete media containing either DMSO vehicle control or paclitaxel. </div> <div> </div> <div>Fixed-cell assays: Cells were plated at 3000 cells in 100ul of complete media per well in a 96 well plate (#08-772-225, FisherScientific). After 24 hours, an additional 100ul of either vehicle (0.1% DMSO) or paclitaxel containing complete media was added. After 72 hours cells were fixed with 4% Formaldehyde (#28908, ThermoFisher Scientific) for 15 minutes at room temperature, then permeabilized with 0.3% Triton X-100 (#X100-100ML, Sigma Aldrich) for 10 minutes at room temperature, then washed twice with PBS. Fixed cells were then stained with 0.5ug/mL DAPI (4083S, Cell Signaling Technology) in PBS for 15 minutes at room temperature. Following DAPI staining, wells were washed once with PBS, then stained with 1:20,000 HCS CellMask Green in PBS (H32714, Invitrogen) for 15 minutes at room temperature. Wells were washed twice with room temperature PBS and then 4 fields of view per well imaged on an InCell 6000 (GE Healthcare). Images were segmented with two custom Cellpose models to segment the nucleus (using parameters: diameter = 50, chan = DAPI, chan2 = Cellmask Orange) and cytoplasm (using parameters: diameter = 90, chan = Cellmask Orange, chan2 = DAPI). Image quantification was performed in R (v4.3.1) using EBImage (v4.42.0), and cells were annotated based on the number of distinct nuclei segmented within each cytoplasmic mask. </div> <div> </div> <div>HDHB reporter live-cell assays: siRNA knockdown and drug treatment was performed as described above, and then the plate was loaded on an Incucyte S3 (Sartorious) and cells imaged every 15 minutes for 72 hours post drug treatment. At each timepoint 4 fields of view were captured at 20x magnificantion in each well using the phase, red and green channels. A cytoplasmic mask was computed from the mean of normalized red/green channel (cellpose parameters: diameter = 57, chan = mean(normalized(red), normalized(green)), and a nuclear mask was computed from the red channel (cellpose parameters: diameter = 30, chan = DAPI) using custom trained Cellpose models. Image quantification was performed in R (v4.3.1) using EBImage (v4.42.0). An additional perinuclear ring mask was computed as the 11 pixel dilation from the nuclear mask, but still bound by the cytoplasmic mask. To determine mClover localization thresholds for cell cycle assignment, 250 cell images were randomly selected and manually assigned to the G1, S/G2 or M cell cycle state based on mClover localization. The mClover intensity ratios were then used to determine thresholds for automated cell cycle phase calling which was applied to the rest of the data set (Supplemental Figure 5A). Mononuclear cells with a Perinuclear:Nuclear mean intensity ratio greater than 0.8 and Nuclear:Cytoplasmic total intensity less than 0.5 were assigned to the S/G2 phase. Mononuclear and Multinuclear cells with a Nuclear:Cytoplasmic total intensity ratio greater than 0.8 and Perinuclear:Nuclear mean intensity ratio less than 0.8 were assigned to the ‘M’ phase. The remainder of mononuclear cells were assigned ‘G1’, and the remainder of multinucleated cells were assigned ‘Multinucleated’. </div> <div> </div> <div>Included files:</div> <div>fixed_level_1-plate_#.zip : Six .zip archives containing the raw images (DAPI/CellMask/Brightfield) from fixed-cell experiments.</div> <div>plate 1: HCC1143 cells treated with plate A schema</div> <div>plate 2: HCC1143 cells treated with plate B schema</div> <div>plate 3: HCC1806 cells treated with plate A schema</div> <div>plate 4: HCC1806 cells treated with plate B schema</div> <div>plate 5: MDA-MB-468 cells treated with plate A schema</div> <div>plate 6: MDA-MB-468 cells treated with plate B schema</div> <div>fixed_level_2: Data quantified from cellpose masks at the single-nuclei level (redundant cytoplasm information)</div> <div>fixed_level_3: Data from 'fixed_level_2.csv' collapsed to the single cell level, including staining intensity and aggregate nuclear information</div> <div>fixed_incell_to_cellpose.rmd: R markdown code for converting original incell files (fixed_level_1) to RGB images for cellpose segmentation</div> <div>fixed_image_quantification.rmd: R markdown code for quantifying images using cellpose segmentation masks and original images (fixed_level_1)</div> <div>fixed_cellpose_models.zip: Archive including cellpose models used for fixed experiment</div> <div>live_level_2: Data quantified from cellpose masks at the single-nuclei level (redundant cytoplasm information)</div> <div>live_level_3: Data from 'live_level_2.csv' collapsed to the single cell level, including staining intensity and aggregate nuclear information</div> <div>live_level_4: Data from 'live_level_3.csv' collapsed to the single condition level summarizing the number, multinucleation status and phase of cells at each time point.</div> <div>live_image_quantification.rmd: R markdown code for quantifying images using cellpose segmentation masks and original images (live_level_1).</div> <div>l ive_incu_archive2rgb.rmd: R markdown code for converting incucyte archive formatted data into RGB images, where the blue channel is the arithmetic mean of the min-max (0-1) normalized red and green channels.</div> <div>live_cellpose_models.zip: Archive including cellpose models used for live experiment.</div> <div> </div> <div> </div>
Impact of paclitaxel treatment on the Triple Negative Breast Cancer Cell line HCC1143
<div>Data and code related to Zenodo repository: 10.5281/zenodo.11237850</div> <div> </div> <div>Experimental goal:</div> <div>Evaluate the impact of escalating paclitaxel dose on cell count, nuclear morphology and cellular outcome.</div> <div> </div> <div>Methods:</div> <div>Cells were plated at 3000 cells in 100ul of complete media per well in a 96 well plate (#08-772-225, FisherScientific). After 24 hours, an additional 100ul of either vehicle (0.1% DMSO) or paclitaxel containing complete media was added. After 72 hours cells were fixed with 4% Formaldehyde (#28908, ThermoFisher Scientific) for 15 minutes at room temperature, then permeabilized with 0.3% Triton X-100 (#X100-100ML, Sigma Aldrich) for 10 minutes at room temperature, then washed twice with PBS. Fixed cells were blocked with 1% BSA (A7906-100G, Millipore Sigma) in PBS for 1 hour at room temperature and then stained overnight with 1:100 anti-CDKN2A/p16INK4A+CDKN2B/p15INK4B-AF644 (#ab199756, Abcam), and 1:100 anti-cPARP-AF647 (#6987S, Cell Signaling Technology) or 1:500 anti-TUBB3-AF647 (#ab190575, Abcam) overnight at 4C. Each well was washed twice with room temp PBS then stained with 0.5ug/mL DAPI (4083S, Cell Signaling Technology) in PBS for 15 minutes at room temperature. Following DAPI staining, wells were washed once with PBS, then stained with 1:20,000 HCS CellMask in PBS (Orange: #H32713, Green: #H32714, Invitrogen) for 15 minutes at room temperature. Wells were washed twice with room temperature PBS and then 4 fields of view per well imaged on an InCell 6000 (GE Healthcare). Images were segmented with two custom Cellpose models to segment the nucleus (using parameters: diameter = 45, chan = DAPI, chan2 = Cellmask Orange) and cytoplasm (using parameters: diameter = 90, chan = Cellmask Orange, chan2 = DAPI). Image quantification was performed in R (v4.3.1) using EBImage (v4.42.0), and cells were annotated based on the number of distinct nuclei segmented within each cytoplasmic mask. </div> <div> </div> <div>Included files:</div> <div>row_#_level_1.zip : 6 zip file containing original images from InCell 6000, one zip per row</div> <div>level_2.csv : Data quantified to the nuclear level (cytoplasmic quantification is duplicates across multiplet nuclei)</div> <div>level_3.csv: Data quantified at the cellular level including number of nuclei and stain intensities for segmented compartments</div> <div>platemap.csv: Description of each well from the stained plate</div> <div>cellpose_modelz.zip: Zip file containing the two CellPose models used for segmentation</div> <div>image_quantification.rmd : R markdown file containing code for extracting and quantifying image intensities using the raw images (level_1) and segmentation masks created from cellpose.</div>
"The pathway of hyaluronic acid (HA) and its receptors (CD44, RHAMM) in the regulation of Rho GTPases and their effectors in an in vitro colorectal cancer model" ("Szlak kwasu hialuronowego (HA) i jego receptorów (CD44, RHAMM) w regulacji GTPaz Rho i ich efektorów w modelu raka jelita grubego in vitro"); NCN Miniatura 2022/06/X/NZ3/00848
<p>Results from Screening for "The pathway of hyaluronic acid (HA) and its receptors (CD44, RHAMM) in the regulation of Rho GTPases and their effectors in an in vitro colorectal cancer model" the project <strong>Miniatura</strong> (<strong>2022/06/X/NZ3/00848</strong>) funded by Polish <strong>National Science Centre (NCN)</strong></p> <p>Wyniki skriningu w projekcie "Szlak kwasu hialuronowego (HA) i jego receptorów (CD44, RHAMM) w regulacji GTPaz Rho i ich efektorów w modelu raka jelita grubego in vitro", <strong>Miniatura</strong> (<strong>2022/06/X/NZ3/00848</strong>) finansowanym przez <strong>Narodowe Centrum Nauki (NCN)</strong></p>
Quality of Life of Breast Cancer Patients in Albania
<p>Quality of Life of Breast Cancer Patients in Albania. <span>For this study, the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ – C30) questionnaire was used</span></p>
Robust estimation of cancer and immune cell-type proportions from bulk tumor ATAC-Seq data.
<p>Bulk ATAC-seq data of tumour samples result in an averaged signal across different cell-types (cancer, stromal, vascular and immune cells). We propose a deconvolution framework called EPIC-ATAC (<a href="https://doi.org/10.7554/eLife.94833.1">https://doi.org/10.7554/eLife.94833.1</a>), which relies on newly identified cell-type specific ATAC-Seq marker peaks and reference profiles for all major cancer-relevant cell-types to predict the proportions of each cell-type.</p> <p>To evaluate EPIC-ATAC, we generated a bulk ATAC-Seq dataset from peripheral blood mononuclear cells (PBMCs) samples, from which the number of cells in each cell-type has been estimated using flow cytometry, as ground truth for cell proportions. The data provided in this Zenodo deposit correspond to:</p> <p>- The raw counts matrix for each peak called in this ATAC-Seq dataset: PBMC_counts.txt</p> <p>- The normalized (TPM-like) counts matrix for each peak called in this ATAC-Seq dataset: PBMC_counts_norm.txt</p> <p>- The cell fractions of each cell type in each sample: PBMC_cell_fractions.txt</p> <p>- The peaks called in each sample using MACS2 (*narrow.peaks): *_normalized.narrowPeak</p> <p>- Bed files listing ATAC-Seq fragments for each sample: *.bed</p> <p>We also evaluated EPIC-ATAC on multiple pseudobulks generated from single-cell ATAC-Seq data. We provide rds files containing the pseudobulks data used in our work for the evaluation of EPIC-ATAC. The rds files are located in the zip file "pseudobulks.zip".</p> <p>The file "additional_data.zip" contains additional files used to generate the reference profiles in EPIC-ATAC and to reproduce the main analyses performed in the manuscript: <a href="https://doi.org/10.7554/eLife.94833.1">https://doi.org/10.7554/eLife.94833.1</a>. These files are required to run the code available on the following GitHub repository: GfellerLab/EPIC-ATAC_manuscript. </p>
Single-cell RNA-seq of breast cancer infiltrating T cells (case 1)
<p>Single cell suspensions were generated from two individual TNBC primary tumor samples (this entry contains case 2) and the viable cells were FACS sorted for CD3<sup>+</sup> T cells. Sorted cells were then counted and assessed for viability. Single cell library preparation was carried out as per the 10X Genomics Chromium Single cell protocol for the v2 reagent kit (10X Genomics, Pleasanton, CA, USA). Cell suspensions were loaded onto a Chromium Single Cell Chip along with the reverse transcription (RT) mastermix and single cell 3’ gel beads. Following generation of single cell gel bead-in-emulsions (GEMs), reverse transcription was performed using a C1000 Touch Thermal Cycler with a Deep Well Reaction Module (Bio-Rad Laboratories, Hercules, CA, USA). Amplified cDNA was purified using SPRIselect beads (Beckman Coulter, Lane Cove, NSW, Australia) and sheared to approximately 200bp with a Covaris S2 instrument (Covaris, Woburn, MA, USA) using the manufacturer’s recommended parameters. Sequencing libraries were generated with unique sample indices (SI) for each sample. Libraries were sequenced on an Illumina HiSeq 2500 High Output Mode using V4 clustering and sequencing chemistry.</p> <p>This dataset contains the raw .bcl files.</p>
Single-cell RNA-seq of breast cancer infiltrating T cells (case 2)
<p>Single cell suspensions were generated from two individual TNBC primary tumor samples (this entry contains case 1) and the viable cells were FACS sorted for CD3<sup>+</sup> T cells. Sorted cells were then counted and assessed for viability. Single cell library preparation was carried out as per the 10X Genomics Chromium Single cell protocol for the v2 reagent kit (10X Genomics, Pleasanton, CA, USA). Cell suspensions were loaded onto a Chromium Single Cell Chip along with the reverse transcription (RT) mastermix and single cell 3’ gel beads (this sample was divided into two channels). Following generation of single cell gel bead-in-emulsions (GEMs), reverse transcription was performed using a C1000 Touch Thermal Cycler with a Deep Well Reaction Module (Bio-Rad Laboratories, Hercules, CA, USA). Amplified cDNA was purified using SPRIselect beads (Beckman Coulter, Lane Cove, NSW, Australia) and sheared to approximately 200bp with a Covaris S2 instrument (Covaris, Woburn, MA, USA) using the manufacturer’s recommended parameters. Sequencing libraries were generated with unique sample indices (SI) for each sample. Libraries were sequenced on an Illumina HiSeq 2500 High Output Mode using V4 clustering and sequencing chemistry.</p> <p>This dataset contains the raw .bcl files.</p>
Identification and Functional Characterization of an Alternative Cancer-derived PD-L1 Isoform (supplemental data)
<p>The enclosed files contain all of the supplemental data from: Identification and Functional Characterization of an Alternative Cancer-derived PD-L1 Isoform. The files include the complete tables in CSV-formatted files.</p>
Model of Canine Cancer Incidence (v 2.0)
<p>The table presents the canine cancer incidence and explanatory factors computed within Swiss municipal units. In detail, the table attributes are the following.</p> <ul> <li><strong>localityNumber</strong> — the unique identifier of Swiss municipal units in 2013 according to the Swiss Federal Office of Statistics.</li> <li><strong>canineCancer_count</strong> — the canine cancer incidence per Swiss municipal unit in 2008 retrieved from Swiss Canine Cancer Registry (SCCR) data.</li> <li><strong>caninePopulation_count</strong> — the count of dogs per Swiss municipal unit in 2008 retrieved from Swiss dog census data.</li> <li><strong>canineCancer_ratio</strong> — the canine cancer incidence ratio in per thousand per Swiss municipal unit in 2008 combining Swiss Canine Cancer Registry data and Swiss dog census data.</li> <li><strong>femaleRatio_percent </strong>— the ratio of female dogs in percent per Swiss municipal unit in 2008 retrieved from Swiss dog census data.</li> <li><strong>ageAverage_years</strong> — the average age of dogs in years per Swiss municipal unit in 2008 retrieved from Swiss dog census data.</li> <li><strong>mixedBreed_percent</strong> — the ratio of mixed breed dogs in percent per Swiss municipal unit in 2008 retrieved from Swiss dog census data.</li> <li><strong>IncomeTaxProCapita_swissFrancs</strong> — the income tax pro capita per Swiss municipal unit in 2008 retrieved from Swiss Federal Tax Administration data.</li> <li><strong>veterinaryCare_distanceMunicipality</strong> —distance to the closes veterinary practice in km computed using the areal extent of Swiss municipal units for 2013 computed using Swiss Yellow Page data.</li> <li><strong>veterinaryCare_distanceDasymetric</strong> — distance to the closes veterinary practice in km computed using the dasymetrically refined areal extent of Swiss municipal units for 2013 computed using Swiss Yellow Page data.</li> <li><strong>humanDensity_municipality</strong> — human population density in 1,000 people/km2 computed using the areal extent of Swiss municipal units in 2008 computed using Swiss Federal Statistical Office data.</li> <li><strong>humanDensity_dasymetric</strong> — human population density in 1,000 people/km2 computed using the dasymetrically refined areal extent of Swiss municipal units in 2008 computed using Swiss Federal Statistical Office data.</li> </ul>
Cancer related protein visualized by using Discovery Studio Visualizer
<p>Cancer related Protein visualized by using Discovery Studio Visualizer</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.